Expression and clinical significance of histamine receptors in pediatric AML
Background This study investigates the expression and clinical significance of the histamine receptor family (HRs) in the bone marrow of children with newly diagnosed acute myeloid leukemia (AML).Methods RNA sequencing was performed to assess the expression levels of HR family members (HRH1, HRH2, H...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Hematology |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/16078454.2024.2449319 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850139887077949440 |
|---|---|
| author | Bi Zhou WenPeng Wang Pao Yu Yang Yang DaWei Mi YuanYuan Tian Ying Li Feng Zhu |
| author_facet | Bi Zhou WenPeng Wang Pao Yu Yang Yang DaWei Mi YuanYuan Tian Ying Li Feng Zhu |
| author_sort | Bi Zhou |
| collection | DOAJ |
| description | Background This study investigates the expression and clinical significance of the histamine receptor family (HRs) in the bone marrow of children with newly diagnosed acute myeloid leukemia (AML).Methods RNA sequencing was performed to assess the expression levels of HR family members (HRH1, HRH2, HRH3, and HRH4) in the bone marrow of 140 pediatric AML patients prior to chemotherapy. We compared the expression levels across various risk categories and assessed their relationship with prognosis using ROC curve analysis to evaluate predictive capabilities for outcomes.Results Among the 140 AML patients in our center, those with different FAB subtypes showed varying overall survival (OS), event-free survival (EFS), and relapse-free survival (RFS). Specifically, the M2 and M4 subtypes showed better OS, EFS, and RFS, whereas the M5 subtype had poorer outcomes. Among patients with different fusion genes, those with AML1/ETO had superior OS, EFS, and RFS compared to other subtypes. Additionally, patients with CEBPA mutations demonstrated relatively favorable outcomes, whereas those with FLT3 mutations had poorer survival metrics. HRH1 expression was significantly higher in AML patients than in normal controls (P < 0.05). Patients in the high HRH1 expression group had significantly better EFS and RFS than those in the low expression group (P < 0.05). Furthermore, HRH1 expression was significantly higher in the low-risk (LR) group than in the intermediate and high-risk (IR & HR) groups (P < 0.05). This finding suggests that HRH1 may serve as an early predictor of risk, EFS, and RFS.Conclusion The clinical significance of HR family members varies in pediatric AML, with HRH1 identified as a valuable predictor of relapse in children with AML. |
| format | Article |
| id | doaj-art-1e0d6046f4e34ad3a892d3b944c4a6d4 |
| institution | OA Journals |
| issn | 1607-8454 |
| language | English |
| publishDate | 2025-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Hematology |
| spelling | doaj-art-1e0d6046f4e34ad3a892d3b944c4a6d42025-08-20T02:30:04ZengTaylor & Francis GroupHematology1607-84542025-12-0130110.1080/16078454.2024.2449319Expression and clinical significance of histamine receptors in pediatric AMLBi Zhou0WenPeng Wang1Pao Yu2Yang Yang3DaWei Mi4YuanYuan Tian5Ying Li6Feng Zhu7Department of Pediatrics, Suzhou Hospital of Anhui Medical University, Suzhou, People’s Republic of ChinaDepartment of Pediatrics, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, People’s Republic of ChinaDepartment of Pediatrics, Suzhou Hospital of Anhui Medical University, Suzhou, People’s Republic of ChinaDepartment of Oncology, Suzhou Hospital of Anhui Medical University, Suzhou, People’s Republic of ChinaDepartment of Stomatology, Suzhou Hospital of Anhui Medical University, Suzhou, People’s Republic of ChinaInstitute of Pediatric Research, Children’s Hospital of Soochow University, Suzhou, People’s Republic of ChinaDepartment of Pediatrics, Suzhou Hospital of Anhui Medical University, Suzhou, People’s Republic of ChinaDepartment of Pediatrics, Suzhou Hospital of Anhui Medical University, Suzhou, People’s Republic of ChinaBackground This study investigates the expression and clinical significance of the histamine receptor family (HRs) in the bone marrow of children with newly diagnosed acute myeloid leukemia (AML).Methods RNA sequencing was performed to assess the expression levels of HR family members (HRH1, HRH2, HRH3, and HRH4) in the bone marrow of 140 pediatric AML patients prior to chemotherapy. We compared the expression levels across various risk categories and assessed their relationship with prognosis using ROC curve analysis to evaluate predictive capabilities for outcomes.Results Among the 140 AML patients in our center, those with different FAB subtypes showed varying overall survival (OS), event-free survival (EFS), and relapse-free survival (RFS). Specifically, the M2 and M4 subtypes showed better OS, EFS, and RFS, whereas the M5 subtype had poorer outcomes. Among patients with different fusion genes, those with AML1/ETO had superior OS, EFS, and RFS compared to other subtypes. Additionally, patients with CEBPA mutations demonstrated relatively favorable outcomes, whereas those with FLT3 mutations had poorer survival metrics. HRH1 expression was significantly higher in AML patients than in normal controls (P < 0.05). Patients in the high HRH1 expression group had significantly better EFS and RFS than those in the low expression group (P < 0.05). Furthermore, HRH1 expression was significantly higher in the low-risk (LR) group than in the intermediate and high-risk (IR & HR) groups (P < 0.05). This finding suggests that HRH1 may serve as an early predictor of risk, EFS, and RFS.Conclusion The clinical significance of HR family members varies in pediatric AML, with HRH1 identified as a valuable predictor of relapse in children with AML.https://www.tandfonline.com/doi/10.1080/16078454.2024.2449319Histamine receptorpediatricAMLprognosis |
| spellingShingle | Bi Zhou WenPeng Wang Pao Yu Yang Yang DaWei Mi YuanYuan Tian Ying Li Feng Zhu Expression and clinical significance of histamine receptors in pediatric AML Hematology Histamine receptor pediatric AML prognosis |
| title | Expression and clinical significance of histamine receptors in pediatric AML |
| title_full | Expression and clinical significance of histamine receptors in pediatric AML |
| title_fullStr | Expression and clinical significance of histamine receptors in pediatric AML |
| title_full_unstemmed | Expression and clinical significance of histamine receptors in pediatric AML |
| title_short | Expression and clinical significance of histamine receptors in pediatric AML |
| title_sort | expression and clinical significance of histamine receptors in pediatric aml |
| topic | Histamine receptor pediatric AML prognosis |
| url | https://www.tandfonline.com/doi/10.1080/16078454.2024.2449319 |
| work_keys_str_mv | AT bizhou expressionandclinicalsignificanceofhistaminereceptorsinpediatricaml AT wenpengwang expressionandclinicalsignificanceofhistaminereceptorsinpediatricaml AT paoyu expressionandclinicalsignificanceofhistaminereceptorsinpediatricaml AT yangyang expressionandclinicalsignificanceofhistaminereceptorsinpediatricaml AT daweimi expressionandclinicalsignificanceofhistaminereceptorsinpediatricaml AT yuanyuantian expressionandclinicalsignificanceofhistaminereceptorsinpediatricaml AT yingli expressionandclinicalsignificanceofhistaminereceptorsinpediatricaml AT fengzhu expressionandclinicalsignificanceofhistaminereceptorsinpediatricaml |